STOCK TITAN

CMA Form 4: Chausse option exercise and 1,600-share withholding

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Comerica Inc. (CMA) insider activity: Sr EVP & Chief Credit Officer Melinda A. Chausse exercised employee stock options for 2,450 shares at $32.97 on 10/30/2025 (Code M). The filing also shows 1,600 shares disposed at $77.09 (Code F), reflecting shares withheld to cover the exercise price and tax obligations. Following these transactions, she directly owned 61,136 shares. A 2017 option grant was fully exercised; additional option grants remain outstanding with expirations from 2027 to 2034.

Positive

  • None.

Negative

  • None.

Insights

Routine option exercise with tax withholding; holdings updated.

Melinda A. Chausse exercised 2,450 options at $32.97 (Code M) and had 1,600 shares withheld at $77.09 (Code F) to cover exercise price and taxes. These are standard mechanics for equity compensation.

Post-transaction, direct ownership is 61,136 shares. A 2017 grant was fully exercised; several option grants remain outstanding with expirations between 2027 and 2034. Actual market impact depends on future holder actions; no sale program is indicated in the excerpt.

Insider CHAUSSE MELINDA A.
Role Sr EVP & Chief Credit Officer
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) 2,450 $32.97 $81K
Exercise Common Stock 2,450 $32.97 $81K
Tax Withholding Common Stock 1,600 $77.09 $123K
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
Holdings After Transaction: Employee Stock Option (right to buy) — 0 shares (Direct); Common Stock — 62,736 shares (Direct)
Footnotes (1)
  1. Includes shares acquired through employee stock plans, shares purchased with reinvested dividends and restricted stock units as of October 30, 2025. Reflects shares withheld for payment of exercise price and to satisfy tax withholding obligations. The options vest in four equal annual installments (based on the original grant amount) beginning on the date indicated in this column.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CHAUSSE MELINDA A.

(Last) (First) (Middle)
1717 MAIN STREET

(Street)
DALLAS TX 75201

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COMERICA INC [ CMA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr EVP & Chief Credit Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/30/2025 M 2,450 A $32.97 62,736(1) D
Common Stock 10/30/2025 F 1,600(2) D $77.09 61,136(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $32.97 10/30/2025 M 2,450 01/26/2017(3) 01/26/2026 Common Stock 2,450 $32.97 0 D
Employee Stock Option (right to buy) $67.66 01/24/2018(3) 01/24/2027 Common Stock 1,295 1,295 D
Employee Stock Option (right to buy) $95.25 01/23/2019(3) 01/23/2028 Common Stock 1,035 1,035 D
Employee Stock Option (right to buy) $80.17 01/22/2020(3) 01/22/2029 Common Stock 1,365 1,365 D
Employee Stock Option (right to buy) $63.15 01/28/2021(3) 01/28/2030 Common Stock 2,425 2,425 D
Employee Stock Option (right to buy) $60.12 01/26/2022(3) 01/26/2031 Common Stock 3,140 3,140 D
Employee Stock Option (right to buy) $92.58 01/25/2023(3) 01/25/2032 Common Stock 2,110 2,110 D
Employee Stock Option (right to buy) $71.16 01/24/2024(3) 01/24/2033 Common Stock 3,050 3,050 D
Employee Stock Option (right to buy) $53.96 01/23/2025(3) 01/23/2034 Common Stock 3,670 3,670 D
Explanation of Responses:
1. Includes shares acquired through employee stock plans, shares purchased with reinvested dividends and restricted stock units as of October 30, 2025.
2. Reflects shares withheld for payment of exercise price and to satisfy tax withholding obligations.
3. The options vest in four equal annual installments (based on the original grant amount) beginning on the date indicated in this column.
Remarks:
Ex. 24 - Power of Attorney
/s/ Nicole V. Gersch, on behalf of Melinda A. Chausse through Power of Attorney 10/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Comerica (CMA) report in this Form 4?

The Sr EVP & Chief Credit Officer exercised 2,450 options at $32.97 and had 1,600 shares withheld at $77.09, ending with 61,136 shares owned directly.

What is the transaction date for the CMA insider activity?

The transactions occurred on 10/30/2025.

How many shares does the reporting person own after the transactions?

Direct ownership is 61,136 shares following the reported transactions.

What do the Form 4 transaction codes M and F mean here?

Code M reflects an option exercise for 2,450 shares at $32.97; Code F reflects 1,600 shares withheld to cover the exercise price and taxes at $77.09.

Which option grant was fully exercised in the CMA filing?

The 2017 option grant with a $32.97 exercise price was fully exercised (0 remaining).

What is the role of the reporting person at Comerica (CMA)?

She is Sr EVP & Chief Credit Officer.

Are there remaining option grants outstanding for the reporting person?

Yes, multiple grants remain outstanding with expirations from 2027 through 2034.